ϩ -sensitive/reference microelectrodes were used to record SD, SD-like depolarizations, and SI in rats in vivo; microelectrodes and intrinsic optical signal measurements were used to record SD and SD-like depolarizations in human and rat brain slices. 
S preading depression (SD) is a slowly propagating neuroglial depolarization wave 1 that is not deleterious to neuronal tissue. 2 In contrast, in the ischemic penumbra, SD-like depolarizations occur 3, 4 that are preceded by a gradual increase of the extracellular K ϩ concentration ([K ϩ ] o ) 5, 6 and may augment neuronal damage. 7 If, in addition to elevated [K ϩ ] o , the nitric oxide concentration is reduced, SD-like depolarizations induce ischemic blood flow changes that propagate with the depolarization wave (spreading ischemia [SI] ). 8, 9 It has been proposed that SI may underlie the laminar cortical infarcts that represent the predominant infarct pattern in autopsy studies after subarachnoid hemorrhage (SAH), because SI: (1) induces focal cortical pan necrosis 10, 11 ; (2) can be triggered by products of erythrocytolysis 8 ; and (3) is prevented by drugs clinically used for the prophylaxis of infarcts after SAH. 12 N-methyl-D-aspartate receptor (NMDAR) antagonists have been regarded promising candidates to inhibit SD-like depolarizations and SI, because they block SD under physiological conditions. [13] [14] However, their efficacy seems to be reduced under energy depletion. [15] [16] [17] Here, we have studied whether elevated baseline [K ϩ ] o may be the cause of this reduced drug efficacy.
Materials and Methods
Chemicals were purchased from Sigma-Aldrich unless otherwise stated. All experiments conformed to institutional guidelines and were approved by an official committee.
In Vivo Experiments
Male Wistar rats (250 to 450 grams; Charles River Laboratories, Wilmington, Mass) were anesthetized with 100 mg/kg thiopental (BYK-Chemie) intraperitoneally, tracheotomized, and ventilated (Rodent-Respirator; Effenberger). Saline solution was infused through the femoral artery. Mean arterial pressure, PaO 2 , PaCO 2 , and pH were monitored. Body temperature was maintained at 38.0Ϯ0.5°C. After craniotomy and dura removal, a single cranial window was implanted in groups 1 to 3, and 2 windows in group 4. 8 The cortex was continuously superfused with carbogenated artificial cerebrospinal fluid (ACSF) containing (mmol) 152 Na ϩ , 3 K ϩ , 1. ϩ -selective/reference microelectrodes (300 m depth). Subarachnoid DC potential and electrocorticogram were recorded by an AgCl electrode. The parameters were recorded using a chart recorder (DASH-IV; Astro-Med). Absolute DC potential and [K ϩ ] o changes were analyzed; cerebral blood flow changes were calculated in relation to baseline at the onset of experiments (100%; zero levels were established at the end of experiments after global ischemia).
Brain Slices and Measurement of SD
Wistar rats (150 to 200 grams) were decapitated under ether anesthesia. Coronal neocortical slices (400 m) were obtained using a vibratome (WPI) and perfused with prewarmed carbogenated ACSF containing (mmol) 126 NaCl, 3 KCl, 2 MgSO 4 , 2 CaCl 2 , 10 glucose, 1.25 NaH 2 PO 4 , and 26 NaHCO 3 (pH 7.4) in an interfacetype chamber. Human neocortical tissue was obtained from patients undergoing surgery for pharmacoresistent epilepsy. The study was conducted according to the Declaration of Helsinki and approved by the local ethics committee (patients gave written informed consent). Slices (400 m) were prepared as described. 18 DC potential amplitude, duration at half-maximal amplitude (T 1 ⁄2max), and [K ϩ ] o were recorded by 2 K ϩ -selective/reference microelectrodes in layers II/III and digitized with a DASH-8u recorder (Astro-Med). Intrinsic optical signals were monitored by transilluminating slices and recorded using a microscope-mounted CCD camera. The control image in a series, captured before SD, was subtracted from each subsequent image, revealing changes in light transmittance (LT) over time. Regions of interest were selected to quantify and compare LT changes. SD velocity was determined by the propagation of the transient LT decrease.
Results
The systemic variables of the in vivo experiments remained within physiological limits ( Table 1 ). The experimental data are summarized in Tables 2 and 3 .
NMDAR Blockade Does not Inhibit SI
In group 1, we generated SI by continuously applying the nitric oxide scavenger hemoglobin (2.5 mmol/L) and increasing [ Data are given for spreading ischemia (SI, groups 1 and 2), SD-like depolarizations (SDLD) and spreading depression (SD; groups 3 and 4). In groups 1 to 3, one cranial window was superfused and data are given for the caudal and rostral probes. In group 4, data are given for 2 separately superfused windows. SI was generated in absence (group 1) and presence (group 2) of MK-801. In groups 3 and 4, data are given for depolarizations before and after the administration of MK-801.
CBF SI was characterized by a long-lasting cerebral blood flow decrease to ischemic levels, followed by a transient hyperemia (Table 2 and Figure 1A ). These flow changes were accompanied by a transient negativation of the DC potential and a transient peak of [K ϩ ] o . The delay between the onset of the hypoperfusion at the 2 laser probes indicated a propagation of the ischemic flow changes. This group was compared with group 2 (nϭ6) in which SI was generated by the same protocol, but the noncompetitive NMDAR antagonist MK-801 (5 mg/kg) was bolus-injected twice intravenously: at normal and at elevated [ 10 There was a delay between the recording sites at the window, indicating a propagation of the neurovascular changes ( Figure 1B) . Compared with SI (groups 1 to 2), the DC shift duration and the extent and duration of the hypoperfusion were significantly smaller (PϽ0.001, Student t test). After 3 SD-like depolarizations had been recorded, the perfusion was switched to physiological ACSF and MK-801 was bolus-injected. slices. The electrophysiological and optical parameters did not differ significantly. An example is given in Figure 3A . The same protocol was followed in group 6 (nϭ6), As previously reported, 6 SD was completely blocked in slices perfused with physiological ACSF and either MK-801 (group 7, nϭ6) or 2-APV (group 8, nϭ6), in which SD was triggered by local microinjection of 3 mol/L KCl into layers II/III using a glass capillary. Repetitive SDs were inducible in all control slices. Figure 3B . 
NMDAR Blockade Fails to Inhibit SD-Like Depolarizations in Human Slices

Discussion
We found that NMDAR antagonists did not block SD-like depolarizations or SI when [K ϩ ] o was increased to concentrations similar to those in the ischemic penumbra in vivo 5 or in hypoxic brain slices. 6 Our findings may be relevant for neuroprotective strategies in brain trauma, stroke, and brain hemorrhage, in which the occurrence of SD-like depolarizations has been suggested, 3,4,7,19 -21 and for ischemic infarcts after SAH, which may be caused by SI. 8 -11 Pathological [K ϩ ] o elevations preceding SD-like depolarizations or SI in these conditions may be induced by energy depletion as in the ischemic penumbra, 5, 6 tissue disruption as in brain trauma, 22 or K ϩ release from erythrocytolysis as after SAH. 23 The higher threshold for SD-like depolarizations in human compared with rat brain slices may be related to anticonvulsantinduced or epilepsy-induced altered expression of signaling proteins. However, the latter seems unlikely, because the SD threshold is reduced in epilepsy models in human and rodent tissue. 24 SD-like depolarizations may augment tissue damage. 4, 7 Because NMDAR antagonists block SD in normal tissue, they have been regarded as promising drugs to ameliorate the deleterious effect of SD-like depolarizations. NMDAR inhibitors reduced the frequency of SD-like depolarizations after experimental focal ischemia, 4,16,17 but they had no effect on anoxic depolarization (AD). 6, 13, 14 However, compared with their potent effect on "normal" SDs, the efficacy of NMDAR antagonists on SD-like depolarizations was lower. 4, [15] [16] [17] Likewise, we found that NMDAR antagonists increased the threshold for SD-like depolarizations, but their efficacy was dramatically reduced when [K ϩ ] o was increased, implicating that under pathological conditions, SD-like depolarizations originating in tissue with elevated [K ϩ ] o may not be blocked by NMDAR antagonists. Given the gradual evolution from AD to SD-like depolarizations to SD, these depolarizations may become more susceptible to NMDAR inhibitors as they propagate away from the compromised tissue, suggesting that SD-like depolarizations may still occur in the injured tissue under NMDAR blockade even though they may not be recorded in the infarct periphery. Notably, the therapeutic time window of NMDAR antagonists in some animal models of stroke closes well before the majority of SD-like depolarizations appears, 25 suggesting that effects other than SD inhibition, eg, lowered posthypoxic oxygen consumption, 26 may contribute to their neuroprotective effect. In contrast, it was recently demonstrated that after focal ischemia, delayed application of an NMDAR antagonist reduced infarct size and the frequency of SD-like depolarizations. 4 Moreover, MK-801 inhibited SD-like depolarizations under high [K ϩ ] ACSF in rat brain slices at a higher concentration. 27 However, a threshold shift may have not been detected because of the different experimental designs. Consistent with our findings, glutamate receptor inhibition with kynurenate also increased the K ϩ threshold for SD in the turtle cerebellum in vivo. 28 Because other channels may take over NMDAR-mediated ion currents during ischemia, 1 characterizing the role of these channels during energy compromise may help to develop alternative neuroprotective strategies.
In summary, we showed that in vivo, the efficacy of NMDAR inhibitors on SD-like depolarizations and SI was critically reduced by increased baseline [K ϩ ] o . In human and rat brain slices, NDMAR antagonists rendered the tissue less susceptible to SD-like depolarizations, but they did not inhibit SD-like depolarizations when baseline [K ϩ ] o was increased.
